 BURNABY, British Columbia, Nov. 12, 2021 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a neurology-focused biopharmaceutical company, today announced that Ian Mortimer, Xenons President and Chief Executive Officer, along with Sherry Aulin, Xenons Chief Financial Officer, will participate virtually in the following investor conferences: 